|
AstraZeneca takes latest scientific advances in oncology to major US and European congresses
|
29 November 2016 |
|
AstraZeneca head and neck cancer trials
|
28 October 2016 |
|
AstraZeneca enters agreement with Cilag GmbH International to divest rights to Rhinocort Aqua outside the US
|
07 October 2016 |
|
PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
|
13 September 2016 |
|
Benralizumab phase III trials show positive results in severe asthma
|
05 September 2016 |
|
AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer's disease
|
22 August 2016 |
|
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
|
01 July 2016 |
|
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
|
28 June 2016 |
|
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
|
09 June 2016 |
|
AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America
|
02 June 2016 |